| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $1.5 (Beat by $0.07) |
| EPS GAAP Actual | $1.5 (Beat by $0.07) |
| Revenue Actual | $2.161B |
| Revenue Surprise | Beat by $2161M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.49 |
| EPS GAAP Estimate | $1.49 |
| Revenue Estimate | $2.149346719B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 0 |
| Dec 2028 | 6.53 | 10.95 | 6.47742 | 6.58105 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.52 | -0.91 | 2.161B | 3.7% | 34.48M |
| FQ1 2025 (Mar 2025) | 0.79 | -0.44 | 2.07B | 2.61% | 91.39M |
| FQ4 2024 (Dec 2024) | 0.17 | 0.17 | 2.074B | 100% | 2074M |
| FQ3 2024 (Sep 2024) | 0.7 | 0.7 | 2.082B | 100% | 2082M |
| FQ2 2024 (Jun 2024) | 0.51 | 0.51 | 2.081B | 1.8% | 2081M |
| FQ1 2022 (Mar 2022) | 0 | 0 | 2.058B | 100% | 2058M |
| FQ1 2024 (Mar 2024) | 1.37 | 1.37 | 2.016B | -1.36% | 2016M |
| FQ2 2022 (Jun 2022) | 0 | 0 | 2.058B | 100% | 2058M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.49
Consensus Revenue Estimates
2.149346719B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.74 | -- | 1.72472 | 1.76176 | 2 |
| FQ3 2027 (Sep 2027) | 1.6939 | -- | 1.6939 | 1.6939 | 1 |
| FQ2 2027 (Jun 2027) | 1.6856 | -- | 1.6856 | 1.6856 | 1 |
| FQ1 2027 (Mar 2027) | 1.64 | -- | 1.6256 | 1.66051 | 2 |
| FQ4 2026 (Dec 2026) | 1.42 | -- | 1.40573 | 1.44999 | 0 |
| FQ3 2026 (Sep 2026) | 1.5 | -- | 1.48492 | 1.53168 | 0 |
| FQ2 2026 (Jun 2026) | 1.49 | 65.1 | 1.47502 | 1.52147 | 0 |
| FQ1 2026 (Mar 2026) | 1.4 | 43.57 | 1.38593 | 1.42957 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.26B | -- | 2.24B | 2.28B | 2 |
| FQ3 2027 (Sep 2027) | 2.18B | -- | 2.18B | 2.18B | 2 |
| FQ2 2027 (Jun 2027) | 2.2B | -- | 2.2B | 2.2B | 2 |
| FQ1 2027 (Mar 2027) | 2.25B | -- | 2.23B | 2.27B | 2 |
| FQ4 2026 (Dec 2026) | 2.09B | -- | 2.07B | 2.12B | 1 |
| FQ3 2026 (Sep 2026) | 2.11B | -- | 2.09B | 2.14B | 1 |
| FQ2 2026 (Jun 2026) | 2.14B | -1.03 | 2.12B | 2.17B | 1 |
| FQ1 2026 (Mar 2026) | 2.06B | -0.25 | 2.05B | 2.1B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
2
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.43 | 0.52 | -0.91 | -175% |
| FQ1 2025 (Mar 2025) | 1.23 | 0.79 | -0.44 | -55.7% |
| FQ4 2024 (Dec 2024) | 0.17 | 0.17 | 100% | |
| FQ3 2024 (Sep 2024) | 0.7 | 0.7 | 100% | |
| FQ2 2024 (Jun 2024) | 0.51 | 0.51 | 100% | |
| FQ1 2022 (Mar 2022) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 1.37 | 1.37 | 100% | |
| FQ2 2022 (Jun 2022) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $2.13B | $2.16B | $34.48M | 1.6% |
| FQ1 2025 (Mar 2025) | $1.98B | $2.07B | $91.39M | 4.42% |
| FQ4 2024 (Dec 2024) | $0B | $2.07B | $2074M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.08B | $2082M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.08B | $2081M | 100% |
| FQ1 2022 (Mar 2022) | $0B | $2.06B | $2058M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.02B | $2016M | 100% |
| FQ2 2022 (Jun 2022) | $0B | $2.06B | $2058M | 100% |